[Delirium: a reappraisal of clinical characteristics and treatment perspectives after the transition from the DSM-IV to the DSM-5].

[Delirium: a reappraisal of clinical characteristics and treatment perspectives after the transition from the DSM-IV to the DSM-5]. Riv Psichiatr. 2019 Sep-Oct;54(5):218-223 Authors: Abelli M, Pini S, Martinelli R, Forfori F Abstract The aim of this commentary is to discuss some clinical characteristics and treatment perspectives of delirium in the light of transition from the DSM-IV to the DSM-5. Such a transient dysfunction of cerebral metabolism, essentially reversible, presents an acute or subacute onset, and manifests itself clinically through a wide range of neuropsychiatric abnormalities. Delirium is a predictor of cognitive decline and is associated with a greater mortality. First line treatment of delirium is represented by haloperidol though atypical antipsychotics effectiveness and tolerability are increasingly evident. PMID: 31657806 [PubMed - in process]
Source: Rivista di Psichiatria - Category: Psychiatry Tags: Riv Psichiatr Source Type: research
More News: Brain | Neurology | Psychiatry